Anti-angiogenic and anti-scarring dual action of an anti-fibroblast growth factor 2 aptamer in animal models of retinal disease

HIGHLIGHTS

• who: Yusaku Matsuda from the IncUniversity of of Tokyo, Minato-ku, Tokyo, Japan have published the article: Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease, in the Journal: (JOURNAL) of 17/09/2019
• what: The authors determined the KD of the non-PEGylated form of RBM-007 to FGF2 proteins from different species such as human, rat, mouse, and rabbit by a surface plasmon resonance (SPR) assay using a streptavidin sensor chip on which 50 -biotin-labeled RBM-007 oligonucleotide was immobilized . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.